These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10199518)

  • 1. The unorthodox and orthodox: the therapeutic role of acadesine after traumatic injury and sepsis.
    Unkle DW
    Crit Care Med; 1999 Mar; 27(3):468-9. PubMed ID: 10199518
    [No Abstract]   [Full Text] [Related]  

  • 2. Acadesine during fluid resuscitation from shock and abdominal sepsis.
    Melton SM; Moomey CB; Ragsdale DN; Trenthem LL; Croce MA; Fabian TC; Proctor KG
    Crit Care Med; 1999 Mar; 27(3):565-75. PubMed ID: 10199538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acadesine and intestinal barrier function after hemorrhagic shock and resuscitation.
    Ragsdale DN; Proctor KG
    Crit Care Med; 2000 Dec; 28(12):3876-84. PubMed ID: 11153629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous adenosine and secondary injury after chest trauma.
    Davis KA; Fabian TC; Ragsdale DN; Trenthem LL; Proctor KG
    J Trauma; 2000 Nov; 49(5):892-8. PubMed ID: 11086782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury.
    Mullane K
    Cardiovasc Res; 1993 Jan; 27(1):43-7. PubMed ID: 8458030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acadesine on myocardial ischaemia in patients with coronary artery disease.
    de Jonge R; Macleod DC; Suryapranata H; van Es GA; Friedman J; Serruys PW; de Jong JW
    Eur J Pharmacol; 1997 Oct; 337(1):41-4. PubMed ID: 9389379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acadesine: a unique cardioprotective agent for myocardial ischemia.
    Nawarskas JJ
    Heart Dis; 1999; 1(4):255-60. PubMed ID: 11720632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of acadesine in clinical myocardial protection.
    Alkhulaifi AM; Pugsley WB
    Br Heart J; 1995 Apr; 73(4):304-5. PubMed ID: 7756061
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of acadesine on the incidence of myocardial infarction and adverse cardiac outcomes after coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
    Anesthesiology; 1995 Oct; 83(4):658-73. PubMed ID: 7574044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute therapeutic use of 5-aminoimidazole-4-carboxamide ribonucleoside extends survival interval in response to severe hemorrhagic shock.
    Smith Sonneborn J; Rutten M
    Shock; 2011 Aug; 36(2):191-5. PubMed ID: 21765342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine.
    Mangano DT; Miao Y; Tudor IC; Dietzel C; ;
    J Am Coll Cardiol; 2006 Jul; 48(1):206-14. PubMed ID: 16814669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing nature's own cardiac defense mechanism with acadesine, an adenosine regulating agent: importance of the endothelium.
    Engler RL
    J Card Surg; 1994 May; 9(3 Suppl):482-92. PubMed ID: 8069041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat.
    Galiñanes M; Mullane KM; Bullough D; Hearse DJ
    Circulation; 1992 Aug; 86(2):598-608. PubMed ID: 1638725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart.
    Galiñanes M; Bullough D; Mullane KM; Hearse DJ
    Circulation; 1992 Aug; 86(2):589-97. PubMed ID: 1638724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acadesine reduces myocardial infarct size by an adenosine mediated mechanism.
    Zhao ZQ; Williams MW; Sato H; Hudspeth DA; McGee DS; Vinten-Johansen J; Van Wylen DG
    Cardiovasc Res; 1995 Apr; 29(4):495-505. PubMed ID: 7796443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial.
    Newman MF; Ferguson TB; White JA; Ambrosio G; Koglin J; Nussmeier NA; Pearl RG; Pitt B; Wechsler AS; Weisel RD; Reece TL; Lira A; Harrington RA;
    JAMA; 2012 Jul; 308(2):157-64. PubMed ID: 22782417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits.
    Burckhartt B; Yang XM; Tsuchida A; Mullane KM; Downey JM; Cohen MV
    Cardiovasc Res; 1995 May; 29(5):653-7. PubMed ID: 7606753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acadesine, an adenosine-regulating agent with the potential for widespread indications.
    Drew BG; Kingwell BA
    Expert Opin Pharmacother; 2008 Aug; 9(12):2137-44. PubMed ID: 18671468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. SPI Research Group.
    Leung JM; Stanley T; Mathew J; Curling P; Barash P; Salmenpera M; Reves JG; Hollenberg M; Mangano DT
    Anesth Analg; 1994 Mar; 78(3):420-34. PubMed ID: 7818622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acadesine reduces indium-labeled platelet deposition after photothrombosis of the common carotid artery in rats.
    Dietrich WD; Miller LP; Prado R; Dewanjee S; Alexis N; Dewanjee MK; Gruber H
    Stroke; 1995 Jan; 26(1):111-6. PubMed ID: 7839379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.